Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?Zacks Investment Research • 08/05/26
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle ProminencePRNewsWire • 08/04/26
AbbVie (ABBV) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/31/26
AbbVie Bought Apogee to Strengthen Its Portfolio. Now It's Cutting Earnings Guidance.Barrons • 07/31/26
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGEBusiness Wire • 07/30/26
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?The Motley Fool • 07/29/26
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia AreataPRNewsWire • 07/29/26
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental VitiligoPRNewsWire • 07/29/26